down arrow

RaQualia Pharma, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3967150008
  • TKS: 4579
JPY
590.00
-4 (-0.67%)

Sep 24

TKS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
653.60
801.99
1,668.93
775.05
570.56
965.41
738.14
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
653.60
801.99
1,668.93
775.05
570.56
965.41
738.14
Raw Material Cost
228.79
250.71
242.54
226.55
235.29
292.82
350.27
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
16.67
15.99
14.63
15.25
16.21
14.97
14.00
Selling and Distribution Expenses
218.70
234.45
234.93
248.45
221.38
194.42
125.25
Other Expenses
36.78
46.10
34.84
43.94
38.10
37.01
43.48
Total Expenditure (Excl Depreciation)
831.91
962.19
840.47
929.60
853.87
872.30
924.30
Operating Profit (PBDIT) excl Other Income
-178.29999999999998
-160.2
828.5
-154.60000000000002
-283.29999999999995
93.10000000000001
-186.20000000000002
Other Income
27.77
29.00
55.30
34.72
-31.81
-69.13
96.72
Operating Profit (PBDIT)
-35.92
-19.80
1,013.83
1.03
-195.72
141.83
31.92
Interest
16.67
15.99
14.63
15.25
16.21
14.97
14.00
Exceptional Items
-0.20
-11.53
-4.52
-0.17
10.69
20.21
-27.02
Gross Profit (PBDT)
424.81
551.28
1,426.39
548.50
335.28
672.59
387.87
Depreciation
114.63
111.40
130.06
120.86
119.39
117.85
121.36
Profit Before Tax
-167.41
-158.72
864.61
-135.25
-320.64
29.22
-130.46
Tax
73.54
66.97
22.51
78.99
28.89
34.44
24.67
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-240.95
-225.69
842.10
-214.24
-349.53
-5.21
-155.14
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-240.95
-225.69
842.10
-214.24
-349.53
-5.21
-155.14
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-240.95
-225.69
842.10
-214.24
-349.53
-5.21
-155.14
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
7,830.91
8,086.70
6,896.26
6,042.37
6,286.93
5,500.09
5,570.51
Earnings per share (EPS)
-9.26
-8.84
34.43
-8.76
-15.25
-0.24
-7.16
Diluted Earnings per share
-9.26
-8.84
34.43
-8.76
-15.25
-0.24
-7.16
Operating Profit Margin (Excl OI)
-27.28%
-19.97%
49.64%
-19.94%
-49.65%
9.64%
-25.22%
Gross Profit Margin
-8.08%
-5.9%
59.6%
-1.86%
-35.27%
15.23%
-1.23%
PAT Margin
-36.87%
-28.14%
50.46%
-27.64%
-61.26%
-0.54%
-21.02%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 14.55% vs -25.17% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is 31.07% vs -42.19% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 61.13% vs -7.62% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is 3.09% vs 12.50% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of RaQualia Pharma, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
653.60
0.00
653.60
Other Operating Income
0.00
0.00
0.00
Total Operating income
653.60
0.00
653.60
Raw Material Cost
228.79
0.00
228.79
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
16.67
0.00
16.67
Selling and Distribution Expenses
218.70
74.80
143.90
192.38%
Other Expenses
36.78
24.12
12.66
52.49%
Total Expenditure (Excl Depreciation)
831.91
316.02
515.89
163.25%
Operating Profit (PBDIT) excl Other Income
-178.32
-316.02
137.70
43.57%
Other Income
27.77
11.37
16.40
144.24%
Operating Profit (PBDIT)
-35.92
-304.65
268.73
88.21%
Interest
16.67
0.00
16.67
Exceptional Items
-0.20
0.00
-0.20
Gross Profit (PBDT)
424.81
0.00
424.81
Depreciation
114.63
0.00
114.63
Profit Before Tax
-167.41
-304.65
137.24
45.05%
Tax
73.54
0.31
73.23
23,622.58%
Provisions and contingencies
0
0
0.00
Profit After Tax
-240.95
-304.96
64.01
20.99%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-240.95
-304.96
64.01
20.99%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-240.95
-304.96
64.01
20.99%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
7,830.91
2,074.30
5,756.61
277.52%
Earnings per share (EPS)
-9.26
-15.48
6.22
40.18%
Diluted Earnings per share
-9.26
-15.48
6.22
40.18%
Operating Profit Margin (Excl OI)
-27.28%
0.00%
0.00
-27.28%
Gross Profit Margin
-8.08%
0.00%
0.00
-8.08%
PAT Margin
-36.87%
0.00%
0.00
-36.87%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 65.36 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -18.50% vs -51.94% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 14.55% vs -25.17% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit -24.09 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -6.73% vs -126.80% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 31.07% vs -42.19% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -6.37 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -30.53% vs -105.09% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 61.13% vs -7.62% in Jun 2025

Quarterly - Interest
Interest 1.67 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 4.37% vs 9.59% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 3.09% vs 12.50% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -27.28%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Footer loading